Month: January 2015

Ezra Pound, a Major Literary Figure of the 20th Century, “Loved the Movies of Walt Disney”

(p. C5) “Mussolini asked,” in A. David Moody ‘s retelling, “what was his aim in writing The Cantos, and Pound replied, ‘to put my ideas in order’; and Mussolini said, ‘What do you want to do that for?’ ” When the poet turned from this dismissal to economic policy, which had lately become the central obsession of his life, the dictator was unimpressed by Pound’s list of 18 proposals, alighting particularly on his assertion that “in the Fascist state taxes were no longer necessary”: “Have to think about THAT,” Mussolini said and ended the interview. To the fascist dictator, Pound, by any measure one of the 20th century’s major literary figures, merited hardly more bother than a fly.
. . .
(p. C7) . . . he was not always an elitist. He loved the movies of Walt Disney, . . .

For the full review, see:
DAVID MASON. “The Makers of Modernism; Pound’s generous spirit looms over 20th-century literature, and in the early years his megalomania seemed harmless.” The Wall Street Journal (Sat., Dec. 6, 2014): C5 & C7.
(Note: ellipses added; italics in original.)
(Note: the online version of the review has the date Dec. 5, 2014, and has the title “The Tragic Hero of Literary Modernism; Ezra Pound’s generous spirit looms over 20th-century literature, and in the early years his megalomania seemed harmless.” The first part of the title in the print version was intended to cover both the review of the Pound biography and an accompanying review of a biography of the writer and publisher James Laughlin.)

The book under review is:
Moody, A. David. Ezra Pound: Poet: Volume II: The Epic Years. Oxford, UK: Oxford University Press, 2014.

Lower Cost LEDs Will Reduce Light Prices, and Increase Quantity Consumed (Yes, Virginia, There Really Is a Law of Demand)

(p. A29) The growing evidence that low-cost efficiency often leads to faster energy growth was recently considered by both the Intergovernmental Panel on Climate Change and the International Energy Agency. They concluded that energy savings associated with new, more energy efficient technologies were likely to result in significant “rebounds,” or increases, in energy consumption. This means that very significant percentages of energy savings will be lost to increased energy consumption.
. . .
That’s not a bad thing. Most people in the world, still struggling to achieve modern living standards, need to consume more energy, not less. Cheap LED and other more efficient energy technologies will be overwhelmingly positive for people and economies all over the world.

For the full commentary, see:
MICHAEL SHELLENBERGER and TED NORDHAUS. “The Problem With Energy Efficiency.” The New York Times (Thurs., OCT. 9, 2014): A29.
(Note: ellipsis added.)
(Note: the online version of the commentary has the date OCT. 8, 2014.)

Government Encouraged the Dust Bowl of the 1930s

Timothy Egan in The Worst Hard Time helps us to understand the motives and struggles of those who suffered in the Dust Bowl of the 1930s in the Great Plains of the United States. Sometimes he also illuminates the role that the government had in encouraging ordinary people to move to a place that would soon be hell on earth.
In the next few weeks, I will quote several of the most thought-provoking passages of Egan’s book.

Book discussed:
Egan, Timothy. The Worst Hard Time: The Untold Story of Those Who Survived the Great American Dust Bowl. Boston: Houghton Mifflin, 2006.

TransCanada Plans to Use Eminent Domain to Build the Keystone Pipeline

I am not opposed to the Keystone Pipeline on environmental grounds. But I have long believed that property rights should be defended, and that we too readily allow the violation of property rights through eminent domain.
If the Keystone Pipeline can be built without eminent domain, then I am in favor of allowing it. If it can only be built by violating landowners’ property rights, then I oppose it.

(p. 1A) LINCOLN — As the Republican leader in the U.S. Senate pledged quick approval of the Keystone XL pipeline early next year, final offers were landing Tuesday in dozens of Nebraska mailboxes.

TransCanada Corp. said it mailed new offers of right-of-way payments this week to more than 100 Nebraska landowners who have refused to sign an easement contract.
The letters also say the company will pursue eminent domain against landowners who don’t agree to terms by Jan. 16. The company says Nebraska law requires condemnation proceedings to start within two years of the state’s approval of the pipeline route, which occurred Jan. 22, 2013.

For the full story, see:
Joe Duggan. “TransCanada sends final offers to 100-plus Nebraska landowners.” Omaha World-Herald (Weds., DECEMBER 17, 2014): 1A & 3A.
(Note: the online version of the story has the title “Keystone XL pipeline: TransCanada sends final offers to 100-plus Nebraska landowners.”)

Stalin Was “a People Person”

(p. 12) In “Stalin. Volume I: Paradoxes of Power, 1878-1928,” a masterly account that is the first of a projected three-volume study, Kotkin paints a portrait of an autodidact, an astute thinker, “a people person” with “surpassing organizational abilities; a mammoth appetite for work; a strategic mind and an unscrupulousness that recalled his master teacher, Lenin.”

For the full review, see:
JENNIFER SIEGEL. “‘Stalin,’ by Stephen Kotkin.” The New York Times Book Review (Sun., NOV. 30, 2014): 12.
(Note: the online version of the review has the date NOV. 26, 2014, and has the title “‘Stalin,’ by Stephen Kotkin.”)

The book under review is:
Kotkin, Stephen. Stalin: Volume I: Paradoxes of Power, 1878-1928. New York: Penguin Press, 2014.

Double-Blind Clinical Trials Are NOT the Only Source of Good Evidence

(p. 16) Back in her office, . . . [rheumatologist Jennifer Frankovich] found that the scientific literature had no studies on patients like this to guide her. So she did something unusual: She searched a database of all the lupus patients the hospital had seen over the previous five years, singling out those whose symptoms matched her patient’s, and ran an analysis to see whether they had developed blood clots. “I did some very simple statistics and brought the data to everybody that I had met with that morning,” she says. The change in attitude was striking. “It was very clear, based on the database, that she could be at an increased risk for a clot.”
The girl was given the drug, and she did not develop a clot. “At the end of the day, we don’t know whether it was the right decision,” says Chris Longhurst, a pediatrician and the chief medical information officer at Stanford Children’s Health, who is a colleague of Frankovich’s. But they felt that it was the best they could do with the limited information they had.
A large, costly and time-consuming clinical trial with proper controls might someday prove Frankovich’s hypothesis correct. But large, costly and time-consuming clinical trials are rarely carried out for uncommon complications of this sort. In the absence of such focused research, doctors and scientists are increasingly dipping into enormous troves of data that already exist — namely the aggregated medical records of thousands or even millions of patients to uncover patterns that might help steer care.
. . .
(p. 17) . . . , developing a “learning health system” — one that can incorporate lessons from its own activities in real time — remains tantalizing to researchers. Stefan Thurner, a professor of complexity studies at the Medical University of Vienna, and his researcher, Peter Klimek, are working with a database of millions of people’s health-insurance claims, building networks of relationships among diseases. As they fill in the network with known connections and new ones mined from the data, Thurner and Klimek hope to be able to predict the health of individuals or of a population over time. On the clinical side, Longhurst has been advocating for a button in electronic medical-record software that would allow doctors to run automated searches for patients like theirs when no other sources of information are available.
With time, and with some crucial refinements, this kind of medicine may eventually become mainstream. Frankovich recalls a conversation with an older colleague. “She told me, ‘Research this decade benefits the next decade,’ ” Frankovich says. “That was how it was. But I feel like it doesn’t have to be that way anymore.”

For the full story, see:
VERONIQUE GREENWOOD. “Eureka; Dr. DATA; Can Statistical Analysis Tell Us What Clinical Trials Cannot?” The New York Times Magazine (Sun., OCT. 5, 2014): 16-17.
(Note: ellipses, and bracketed name, added.)
(Note: the online version of the story has the date OCT. 3, 2014, and has the title “Eureka; Can Big Data Tell Us What Clinical Trials Don’t?”)

26 Different Drugs Lengthen Healthy Life Span in Mice

(p. F5) For thousands of years, people have sought to escape or outrun their mortality with potions, pills and elixirs, often blended with heavy doses of hope and will.
In the “Epic of Gilgamesh,” a Mesopotamian king searched for the secret of immortality after the death of his best friend. At least three Chinese emperors in the Tang dynasty died after consuming treatments containing lead and mercury that they hoped would make them immortal. In the late 19th century, a French-American physiologist seemed to have found the elixir of life by injecting the elderly and himself with extracts from animal testicles.
. . .
“By targeting fundamental aging processes, we might be able to delay the major age-related chronic diseases instead of picking them off one at time,” said Dr. James Kirkland, a professor of aging research and head of the Robert and Arlene Kogod Center on Aging at the Mayo Clinic. “For example, we don’t want to have situation where we, say, cure cancer and then people die six months later of Alzheimer’s disease or a stroke. It would be better to delay all of these things together.”
This is where the field known as the biology of aging is moving — to develop drugs that will increase life span and what researchers refer to as health span, the period of life when people are able to live independently and free from disease.
Dr. Kirkland said that at least six drugs had been written up in peer-reviewed journals and that he knew of about 20 others that appear to affect life span or health span in mice. The goal is to see if those benefits can be translated into humans to increase their longevity, “to find interventions that we can use in people that might, say, make a person who’s 90 feel like they’re 60 or a person who’s 70 feel like they’re 40 or 50.”
Other researchers are studying centenarians, seeking to understand whether certain genes have carried them past 100 years old and kept them in good health.

For the full story, see:
TRACEY SAMUELSON. “Science (and Quacks) vs. the Aging Process.” The New York Times (Weds., Nov. 19, 2014): F5.
(Note: ellipsis added.)
(Note: the online version of the story has the date NOV. 18, 2014.)

“You Don’t Reach Serendip by Plotting a Course for It”

(p. 320) As John Barth wrote in The Last Voyage of Somebody the Sailor, “You don’t reach Serendip by plotting a course for it. You have to set out in good faith for elsewhere and lose your bearings serendipitously.”28 The challenge for educational institutions, government policy, research centers, funding agencies, and, by extension, all modern medicine, will be how to encourage scientists to lose their bearings creatively. What they discover may just save our lives!

Source:
Meyers, Morton A. Happy Accidents: Serendipity in Modern Medical Breakthroughs. New York: Arcade Publishing, 2007.
(Note: italics in original.)

“It Is the Individual Who Is the Agent of the Action”

(p. C6) Mr. Mischel begins by describing how, in the late 1960s, he and his colleagues devised a straightforward experiment to measure self-control at the Bing Nursery School at Stanford University. In its simplest form, children between the ages of 4 and 6 were given a choice between one marshmallow now or two marshmallows if they waited 15 minutes. Some kids ate the marshmallow right away, but most would engage in unintentionally hilarious attempts to overcome temptation.
. . . About a third of the original subjects, the researchers reported, deferred gratification long enough to get the second treat.
. . . in 2006, . . . Mr. Mischel published a new paper in the prestigious journal Psychological Science. The researchers had done a follow-up study with the students they had tested 40 years before, examining the sort of adults they had grown into. They found that the children who were able to delay gratification had higher SAT scores entering college, higher grade-point averages at the end of college and made more money after college. Perhaps not surprisingly, they also tended to have a lower body-mass index.
. . .
In his commencement address, Adm. McRaven explained his final life lesson with an anecdote: “In SEAL training there is a bell,” he explained. “A brass bell that hangs in the center of the compound for all the students to see. All you have to do to quit–is ring the bell. Ring the bell and you no longer have to wake up at 5 o’clock. Ring the bell and you no longer have to do the freezing cold swims. Ring the bell and you no longer have to do the runs, the obstacle course, the PT–and you no longer have to endure the hardships of training. Just ring the bell.” To ring the bell is to give up.
Interestingly, one of Mr. Mischel’s lesser-known marshmallow experiments had a similar setup, with a bell that the children could ring to call back the experimenter and save them from themselves. For the children, though, ringing the bell was not giving up but calling in the cavalry. His book is an encouraging reminder that, despite all the factors that urge us to indulge, “at the end of that causal chain, it is the individual who is the agent of the action and decides when to ring the bell.” You are ultimately in control of your self.

For the full review, see:
MICHAEL SHERMER. “Willpower and Won’t Power; To resist the tempting treat, kids looked away, squirmed, sang or simply pretended to take a bite.” The Wall Street Journal (Sat., Sept. 20, 2014): C6.
(Note: ellipses added.)
(Note: the online version of the review has the date Sept. 19, 2014, and has the title “Book Review: ‘The Marshmallow Test’ by Walter Mischel; To resist the tempting treat, kids looked away, squirmed, sang or simply pretended to take a bite.”)

The book under review is:
Mischel, Walter. The Marshmallow Test: Mastering Self-Control. New York: Little, Brown and Company, 2014.

As with Airplanes, Lives Must Be Risked to Achieve Routine Safety in Spaceships

(p. A21) SEATTLE — ONE clear winter day in 1909, in Hampshire, England, a young man named Geoffrey de Havilland took off in a twin-propeller motorized flying machine of his own design, built of wood, piano wire and stiff linen hand-stitched by his wife. The launch was flawless, and soon he had an exhilarating sensation of climbing almost straight upward toward the brilliant blue sky. But he soon realized he was in terrible trouble.
The angle of ascent was unsustainable, and moments later de Havilland’s experimental plane crashed, breaking apart into a tangled mass of shards, splinters and torn fabric, lethal detritus that could easily have killed him even if the impact of smashing into the ground did not. Somehow, he survived and Sir Geoffrey — he was ultimately knighted as one of the world’s great aviation pioneers — went on to build an astonishing array of military and civilian aircraft, including the world’s first jet airliner, the de Havilland Comet.
I thought immediately of de Havilland on Friday when I heard that Virgin Galactic’s SpaceShipTwo, a rocket-powered vehicle designed to take well-heeled tourists to the edge of space, had crashed on a flight over the Mojave Desert, killing one test pilot and seriously injuring the other.
. . .
Certainly the Wright brothers and others like de Havilland were involved in what we now view as an epic quest, but many experts of the day were certain that flight, however interesting, was destined to be not much more than a rich man’s hobby with no practical value.
“The public has greatly over-estimated the possibilities of the aeroplane, imagining that in another generation they will be able to fly over to London in a day,” said a Harvard expert in 1908. “This is manifestly impossible.” Two other professors patiently explained that while laymen might think that “because a machine will carry two people another may be constructed that will carry a dozen,” in fact “those who make this contention do not understand the theory of weight sustentation in the air.”
. . .
There will be tragedies like the crash of SpaceShipTwo and nonlethal setbacks such as the fiery explosion, also last week, of a remote-controlled rocket intended for a resupply mission to the International Space Station. There will be debates about how to improve regulation without stifling innovation. Some will say private industry can’t do the job — though it’s not as if the NASA-sponsored Apollo or space shuttle missions went off without a hitch (far from it, sadly).
But at the heart of the enterprise there will always be obsessives like Sir Geoffrey, who forged ahead with his life’s work of building airplanes despite his own crash and, incredibly, the deaths of two of his three sons while piloting de Havilland aircraft, one in an attempt to break the sound barrier. Getting to routine safety aloft claimed many lives along the way, and a hundred years from now people will agree that in that regard, at least, spaceships are no different from airplanes.

For the full commentary, see:
SAM HOWE VERHOVEK. “Not a Flight of Fancy.” The New York Times (Tues., NOV. 4, 2014): A21.
(Note: ellipses added.)
(Note: the online version of the commentary has the date NOV. 3, 2014.)

Obamacare Advisor Says Obscure Law Passed Due to “Stupidity of the American Voter”

(p. A4) Jonathan Gruber, the economist at the heart of a fresh debate about the Affordable Care Act, has had more than a dozen appointments to visit the White House since Democrats began drafting the health law in 2009, records show.
The visits included at least one group meeting with President Barack Obama , as well as appointments with senior administration officials who helped shape the 2010 law that expanded health insurance to millions of Americans.
The White House in recent days has tried to distance itself from Mr. Gruber, a 49-year-old Massachusetts Institute of Technology economist, since a 2013 video surfaced last week in which he said the law passed because of the “huge political advantage” of the legislation’s lacking transparency. He also referred to the “stupidity of the American voter.”
Republicans have seized on the comments as evidence that supporters of the law purposely misled the public about its costs.
“It is amusing to watch Washington liberals discount Mr. Gruber’s truth-telling as a gaffe and disown” his involvement in the law, said Sen. Orrin Hatch (R., Utah).

For the full story, see:
STEPHANIE ARMOUR and COLLEEN MCCAIN NELSON. “Health Adviser Gruber Logged Regular White House Visits.” The Wall Street Journal (Tues., Nov. 18, 2014): A4.
(Note: the online version of the story has the date Nov. 17, 2014.)